CAS NO: | 30914-89-7 |
生物活性 | Flumexadol is a selective and affinity5-HT2Creceptoragonist with aKiof 25 nM for the (+)-enantiomer of Flumexadol, and is 40-fold selective over the 5-HT2Areceptor. Flumexadol is an orally active non-narcotic analgesic[1][2]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体内研究 (In Vivo) | In rats and dogs dosed with14C-Flumexadol (CERM1841), the14C is excreted in the urine. The14C eliminated in the faeces of dog is significantly higher than for rat. Conjugated metabolites, mostly glucuronides, accounted for the greater part of the urinary radioactivity in both species. Biotransformation products are predominantly acids in both species, follows by significant amounts of basic metabolites, with very little neutral substances. The major urinary metabolite in rats is 3-trifluoromethylbenzoic acid and 3-trifluoromethylhipuric acid. In the dog it is 3-trifluoromethylmandelic acid in addition to the benzoic acid and its conjugate. The basic products identified in the urine of both species are unchanged drug and 1-amino-2-hydroxy-2-(3-trifluoromethylphenyl)ethane, with the first predominating[3]. | ||||||||||||||||
分子量 | 231.21 | ||||||||||||||||
性状 | Liquid | ||||||||||||||||
Formula | C11H12F3NO | ||||||||||||||||
CAS 号 | 30914-89-7 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 33.33 mg/mL(144.15 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |